Form 4 Filing for Immunovant, Inc. - Insider Transactions

This filing details transactions made by Atul Pande, a director at Immunovant, Inc. (IMVT). On June 15, 2026, Pande acquired 1500 shares of Common Stock at $8.43 per share and disposed of 1500 shares of Common Stock at $34.02 per share, under a Rule 10b5-1 Plan. Following these transactions, Pande directly holds 116,731 shares. Additionally, an option to purchase 1500 Common Stock was exercised and disposed of, with 69,681 options remaining. Pande also has 20,000 shares held indirectly by a trust. The filing includes a correction to a previous disclosure regarding remaining options.